03:10 PM EDT, 04/30/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lift our 12-month target price to $276 from $229, reflecting a 17.0x our 2025 EPS estimate, near HUM's historical forward average. We lift our 2025 EPS estimate to $16.33 from $16.25 and trim 2026's to 14.15 from $14.54. Q1 EPS of $11.58 vs. $7.23 beat the S&P Capital IQ consensus estimate considerably by $1.51. Unlike many of HUM's peers that already reported Q1 results, HUM's insurance segment benefit ratio actually improved to 87.4% from 89.3% in the prior year, indicating favorable cost trends in the quarter. Despite the positive Q1 performance, HUM faces challenges in its MA business. HUM expects a significant decline of approximately 550,000 individual MA members in 2025, attributed to strategic decisions to exit certain unprofitable plans and counties. HUM affirmed its full-year 2025 adj. EPS guidance of approximately $16.25 and maintained its Insurance segment benefit ratio guidance range of 90.1% to 90.5% for the full year, suggesting potential pressure on margins in upcoming quarters, in our view.